about
Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetesA GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control.Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency.Clinical pharmacokinetics and pharmacodynamics of vildagliptin.Incretin-based therapies: where will we be 50 years from now?GIP: no longer the neglected incretin twin?Biological and functional characteristics of a novel low-molecular weight antagonist of glucose-dependent insulinotropic polypeptide receptor, SKL-14959, in vitro and in vivo.
P2860
Q28762629-93C2F0CD-4B79-4EE4-916C-5D6AEB4FA5CCQ33541007-D0909A72-161F-4312-9FC4-5C8964155BC2Q36259482-F2881744-58CE-475A-8565-01663A8276AAQ37015063-5E7860F6-853D-45D1-A8BB-609CF92838CCQ37984567-DAB62671-8A06-4648-AE2B-64B902B87C59Q39004418-26C93EFE-0F12-486A-9FA8-B6B5E84274F2Q42906338-BFAF8756-3CEB-4153-B392-9D3CF677673EQ44660849-5DDC3ED7-0D8E-4D1E-B5D6-F2D960FBA403
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
GIP as a potential therapeutic agent?
@ast
GIP as a potential therapeutic agent?
@en
type
label
GIP as a potential therapeutic agent?
@ast
GIP as a potential therapeutic agent?
@en
prefLabel
GIP as a potential therapeutic agent?
@ast
GIP as a potential therapeutic agent?
@en
P356
P1476
GIP as a potential therapeutic agent?
@en
P2093
P304
P356
10.1055/S-2004-826176
P577
2004-11-01T00:00:00Z